D
Dyne Therapeutics, Inc. DYN
$14.51 $0.523.72% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -28.83% 7.81% -49.19% 0.83% 1.48%
Total Depreciation and Amortization 11.56% 2.74% 9.77% 3.37% -3.26%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 27.70% 24.91% 40.90% -71.40% 242.81%
Change in Net Operating Assets 29.16% -135.86% 234.17% 112.92% -228.59%
Cash from Operations -25.56% -13.01% -36.02% 30.14% -124.35%
Capital Expenditure 8.74% -324.90% 70.48% -348.69% -132.93%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 116.33% 22.01% -259.17% 106.70% -783.64%
Cash from Investing 109.11% 17.49% -273.64% 106.21% -786.51%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3,784.52% -79.81% -95.26% -6.99% 277,714.97%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 3,784.52% -79.81% -95.26% -6.99% 277,714.97%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 138.06% -27.21% -122.61% 124.09% 1,831.66%